MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

Piedmont Lithium Inc. (PLL)

For the quarter ending 2025-06-30, PLL made $11,857K in revenue. -$9,738K in net income. Net profit margin of -82.13%.

Overview

Revenue
$11,857K
Net Income
-$9,738K
Net Profit Margin
-82.13%
EPS
-$0.44
Unit: Thousand (K) dollars
Revenue Breakdown
    • Spodumene concentrate sales

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
2025-06-30
2025-03-31
2024-09-30
2024-06-30
Revenue11,857 - 27,663 13,227
Costs of sales13,489 19,862 25,010 12,601
Revenue- 19,996 - -
Gross profit (loss)-1,632 134 2,653 626
Loss from equity method investments-1,139 -4,935 -3,514 -4,910
Selling, general and administrative expenses6,425 6,771 9,466 9,330
Exploration costs- - 35 9
Total operating expenses6,425 6,771 9,501 9,339
Restructuring charges401 283 4,563 -
Loss from operations-9,597 -11,855 -14,925 -13,623
Other (loss) income-146 -3,915 -2,399 -288
Interest income537 699 806 653
Interest expense532 560 169 76
Loss on sale of equity method investments- - - -
Total other (expense) income-141 -3,776 -1,762 289
Loss before income taxes-9,738 -15,631 -16,687 -13,334
Income tax benefit- - - -2
Net loss-9,738 -15,631 -16,687 -13,332
Basic (in shares)21,945,000 21,939,000 19,401,000 19,370,000
Basic net loss per weighted-average share (in dollars per share)-0.44 -0.71 -0.86 -0.69
Diluted (in shares)21,945,000 21,939,000 19,401,000 19,370,000
Diluted net loss per weighted-average share (in dollars per share)-0.44 -0.71 -0.86 -0.69
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement

DownloadDownload image
Net loss-$9,738K (26.96%↑ Y/Y)Loss before incometaxes-$9,738K (26.97%↑ Y/Y)Total other (expense)income-$141K (-148.79%↓ Y/Y)Loss from operations-$9,597K (29.55%↑ Y/Y)Interest income$537K (-17.76%↓ Y/Y)Spodumene concentratesales$13,865K Interest expense$532K (600.00%↑ Y/Y)Loss from equitymethod investments-$1,139K (76.80%↑ Y/Y)Gross profit (loss)-$1,632K (-360.70%↓ Y/Y)Total operatingexpenses$6,425K (-31.20%↓ Y/Y)Restructuring charges$401K Other (loss) income-$146K (49.31%↑ Y/Y)Revenue$11,857K (-10.36%↓ Y/Y)Provisional revenueadjustments-$2,008K Costs of sales$13,489K (7.05%↑ Y/Y)Selling, general andadministrative expenses$6,425K (-31.14%↓ Y/Y)